GWPH News and Press, GW Pharmaceuticals Plc From 02/12/21

In the past few months, some big deals have taken place in the cannabis industry. In December 2020, there was news of a near-$4 billion merger including Canadian pot giants Aphria (NASDAQ: APHA) and Tilray (NASDAQ: TLRY) , which will create the largest cannabis company in th...

After sharp gains witnessed in premarket trading, many of the cannabis stocks are in the red again. A notable exception is Sundial Growers (SNDL) which remains ~7.0% higher.Tilray (TLRY) which was up 10% earlier following a ~51% climb on Wednesday is currently down ~28.4%.The intere...

Cannabis stocks are again higher this morning as the Reddit/WSB traders turn their focus to the sector. Marijuana names were already having a party since the beginning of February, given Jazz Pharmaceuticals' (JAZZ) $7.2B deal for medical cannabinoid firm GW Pharma (GWPH) and Tilray's (TLRY) ...

Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m. on Seeking Alpha, iTunes, Stitcher and Spotify. Something is bumbling Another glitzy IPO will begin trading today as a strong streak continues for stocks and the public markets. Bumble, the hot app which...

The CBD market has recently seen a multi-billion dollar deal and HempFusion going public. Co-Founder/CEO Dr. Jason Mitchell and CCO Danny Brody join the show to discuss radical transparency, methodical growth and becoming more efficient during Covid. We also cover the opportunity ...

Jazz Pharmaceuticals (NASDAQ: JAZZ) recently announced plans to acquire cannabinoid-focused biotech GW Pharmaceuticals (NASDAQ: GWPH) in a deal valued at $7.2 billion. In this Motley Fool Live video recorded on Feb. 3 , Fool.com writers Keith Speights and Brian Orell...

After a two-year dark night, a new dawn is here for cannabis investors. Cannabis companies have stronger fundamentals that will drive the sector higher over the next five years. Investors can now have more clarity about which companies have the greatest potential for growth. ...

One of the biggest names in cannabis-based novel medicine announced this week that it will be acquired by a fellow pharmaceutical player. Also this week, new numbers show that Canadian sales of legal cannabis are overtaking sales of unregulated products in the country. ...

Top Cannabis Stocks And Market Performance In the first week of February, marijuana stocks continue increasing in the market adding to gains from January. One acquisition occurring last week could have been a big influence on the market. In detail, Jazz Pharmaceuticals plc ( NASDA...

On Wednesday, Jazz Pharmaceuticals (JAZZ) said it would acquire GW Pharma (GWPH) in a $7.2B deal.Acquisition gives Jazz access to GW's cannibinoid drug for seizures, Epidiolex, as well as other cannibinoid-based therapies in the pipeline.Several other biopharmas are exploring cannibinoid trea...